Pharmaceutical - Licensing

Filter

Current filters:

Licensing

Popular Filters

1 to 25 of 697 results

Blueprint Medicines in up to $265 million deal with Alexion

03-03-2015

Privately-held Blueprint Medicines has entered a strategic collaboration with USA-based Alexion Pharmaceuticals…

Alexion PharmaceuticalsBlueprint MedicinesLicensingPharmaceuticalRare diseases

Endo to divest its American Medical Systems men's and prostate businesses to Boston Scientific

Endo to divest its American Medical Systems men's and prostate businesses to Boston Scientific

03-03-2015

Ireland-headquartered Endo International has entered into a definitive agreement with Boston Scientific…

EndoLicensingMen's HealthPharmaceuticalUSA

Ferring acquires novel drug delivery technology from CTCBIO

24-02-2015

Privately-held Switzerland-headquartered Ferring Pharmaceuticals has signed an agreement with CTCBIO…

CTCBIOFerring PharmaceuticalsLicensingPharmaceutical

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

23-02-2015

US pharma major Bristol-Myers Squibb has signed a definitive agreement to acquire all of the outstanding…

Bristol-Myers SquibbF001287FlexusLicensingMergers & AcquisitionsOncologyPharmaceuticalRigel Pharmaceuticals

Ferring Pharma acquires two Ph III-ready orthobiologics from BioSET

Ferring Pharma acquires two Ph III-ready orthobiologics from BioSET

19-02-2015

Privately-held Switzerland-headquartered Ferring Pharmaceuticals has acquired the assets of USA-based…

AmplexFerring PharmaceuticalsLicensingPharmaceuticalPrefixSwitzerland

Sanofi collaborates with Lead Pharma for autoimmune disease development

Sanofi collaborates with Lead Pharma for autoimmune disease development

18-02-2015

French pharma major Sanofi has entered into a research collaboration and license agreement with privately-held…

Anti-Arthritics/RheumaticsLead PharmaLicensingPharmaceuticalResearchSanofi

Bristol-Myers Squibb gives full responsibility for Erbitux in Japan to Merck

Bristol-Myers Squibb gives full responsibility for Erbitux in Japan to Merck

13-02-2015

German pharmaceuticals and chemicals major Merck KGaA is to end the co-promotion of Erbitux (cetuximab)…

Bristol-Myers SquibbErbituxJapanLicensingMerck & CoOncologyPharmaceutical

Helsinn signs exclusive agreement with Mundipharma for distribution of anamorelin

Helsinn signs exclusive agreement with Mundipharma for distribution of anamorelin

11-02-2015

Swiss oncology specialist Helsinn has signed an exclusive agreement with Mundipharma to distribute and…

anamorelinGastro-intestinalsHelsinnLicensingMarkets & MarketingMundipharmaOncologyPharmaceutical

Cipla enters joint venture in Morocco and eyes Serum Institute of India merger

Cipla enters joint venture in Morocco and eyes Serum Institute of India merger

09-02-2015

Indian pharma company Cipla has announced that its UK subsidiary has entered into a joint venture agreement…

CiplaLicensingMarkets & MarketingMergers & AcquisitionsMoroccoPharmaceutical

ALK Abello 2014 earnings rocket 76%

ALK Abello 2014 earnings rocket 76%

09-02-2015

Denmark-based allergy specialist ALK Abello posted financials this morning, saying it has achieved one…

ALK AbelloAustraliabioCSLCSL LtdFinancialLicensingNew ZealandPharmaceuticalRespiratory and PulmonarySouth Australia

Helsinn partners with Mundipharma to commercialize NEPA in Brazil

Helsinn partners with Mundipharma to commercialize NEPA in Brazil

09-02-2015

Swiss oncology specialist Helsinn has signed an exclusive agreement with Mundipharma for the distribution…

BrazilGastro-intestinalsHelsinnLicensingMundipharmaNEPAPharmaceutical

CrystalGenomics signs agreement for Daewoong to commercialize Acelex in Korea

CrystalGenomics signs agreement for Daewoong to commercialize Acelex in Korea

09-02-2015

Korean biopharma company CrystalGenomics has signed a sales and marketing agreement with Daewoong Pharmaceutical…

AcelexAnti-Arthritics/RheumaticsCrystalGenomicsDaewoongLicensingPharmaceutical

Ligand out-licenses lasofoxifene to Sermonix

03-02-2015

USA-based drugmaker Ligand Pharmaceuticals has signed a license agreement with privately-held Sermonix…

Anti-Arthritics/RheumaticsFablynlasofoxifeneLicensingLigand PharmaceuticalsPharmaceuticalSermonix PharmaceuticalsUSAWomen's Health

Helsinn grants Stendhal rights to NEPA in several Latin America countries

02-02-2015

Family-run Swiss oncology specialist Helsinn has granted exclusive rights to Mexico-based Especificos…

AkynzeoEisaiHelsinnLicensingNEPAnetupitantOncologypalonosetronPharmaceuticalSouth AmericaStendhal

Applied Molecular Transport inks research and license agreement with Janssen on IBD therapy

Applied Molecular Transport inks research and license agreement with Janssen on IBD therapy

28-01-2015

Biopharma company Applied Molecular Transport has entered into a research collaboration and license agreement…

Applied Molecular TransportGastro-intestinalsJanssenJohnson & JohnsonLicensingPharmaceutical

iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

28-01-2015

Ophthalmic specialist iCura Vision has licensed the intellectual property portfolio and associated research…

iCura VisionLicensingOphthalmicsPharmaceuticalUSA

Gedeon Richter enters license and distribution deal with Bayer

Gedeon Richter enters license and distribution deal with Bayer

27-01-2015

Hungary’s largest drugmaker Gedeon Richter says that it has entered into a license and distribution…

BayerEuropeGedeon RichterLicensingLisvyMarkets & MarketingPharmaceuticalReproductiveSouth AmericaWomen's Health

Array acquires worldwide rights to encorafenib from Novartis

Array acquires worldwide rights to encorafenib from Novartis

23-01-2015

Oncology specialist Array Biopharma has reached an agreement with Swiss drug major Novartis to acquire…

Array BioPharmaencorafenibLicensingNovartisOncologyPharmaceutical

Tiziana licenses potential cancer therapy milciclib from Nerviano

Tiziana licenses potential cancer therapy milciclib from Nerviano

20-01-2015

Oncology and immunology specialist Tiziana Life Sciences has exclusively licensed milciclib from Nerviano…

LicensingmilciclibNerviano Medical SciencesOncologyPharmaceuticalResearchTiziana

UCB signs up to $480 million global collaboration with Neuropore on PD

18-01-2015

Neuropore Therapies, a wholly-owned US subsidiary of Austria’s Ever Neuro Pharma, has entered into…

Ever Neuro PharmaGlobalLicensingNeurologicalNeuropore TherapiesNPT200-11PharmaceuticalResearchUCB

Depomed pays over $1 billion for US rights to Janssen’s Nucynta franchise

Depomed pays over $1 billion for US rights to Janssen’s Nucynta franchise

16-01-2015

US specialty drugmaker Depomed has entered into a definitive agreement to acquire the US rights to the…

DepomedGrunenthalJanssenJohnson & JohnsonLicensingNeurologicalNucyntaPharmaceuticalUSA

Sanofi enters strategic agreement with Boehringer Ingelheim on monoclonal antibodies

Sanofi enters strategic agreement with Boehringer Ingelheim on monoclonal antibodies

15-01-2015

French pharma major Sanofi has entered into a strategic agreement with German family-owned peer Boehringer…

Boehringer IngelheimGermanyLicensingPharmaceuticalResearchSanofi

Boehringer opts to take up rights to Oxford BioThera’s oncology target

Boehringer opts to take up rights to Oxford BioThera’s oncology target

14-01-2015

Privately-held, UK-based Oxford BioTherapeutics says that German family-owned pharma major Boehringer…

Boehringer IngelheimLicensingOncologyOxford BioTherapeuticsPharmaceuticalUK

Debiopharm regains rights to alisporivir in hepatitis C from Novartis

Debiopharm regains rights to alisporivir in hepatitis C from Novartis

13-01-2015

Switzerland-based biopharma company Debiopharm has updated its arrangement with Novartis to regain full…

alisporivirDebiopharmLicensingNephrology and HepatologyNovartisPharmaceuticalResearch

1 to 25 of 697 results

COMPANY SPOTLIGHT

Menarini

Back to top